| HOME >> BIOLOGY >> TECHNOLOGY |
About Merriman Capital, Inc.
Merriman Capital, Inc. is a full-service investment banking firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and high net worth investors. Merriman Capital, Inc. is a wholly owned subsidiary of Merriman Holdings, Inc., which is listed on the NASDAQ Stock Market and trades under the symbol "MERR."
Merriman specializes in four growth sector industries: Technology, Telecom, Consumer, Media & Internet and CleanTech Infrastructure. For more information, please go to http://www.merrimanco.com/.
Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) http://www.finra.org and the Securities Investor Protection Corporation (SIPC)
http://www.sipc.org/contact.cfm.
About Circadian Technologies Limited
Circadian Technologies Limited (ASX: CIR; OTCQX: CKDXY) is a biologics drug developer focusing on cancer therapies. It controls exclusive worldwide rights to a significant intellectual property portfolio around Vascular Endothelial Growth Factor (VEGF) C and D. The applications for the VEGF technology, which functions in regulating blood and lymphatic vessel growth, are substantial and broad. Circadian's internal product development programs are focused on novel anti-cancer therapeutics for large unmet needs. Circadian has also licensed rights to some parts of its intellectual property portfolio for the development of other products to ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, including the antibody-based drug IMC-3C5 targeting VEGFR-3.
About OTCQX
The OTCQX marketplace is the premier tier of the U.S. OT
'/>"/>
| SOURCE Merriman Holdings, Inc. Copyright©2010 PR Newswire. All rights reserved |